Hyaluronic Acid in Inflammation and Tissue Regeneration

Wounds

Volumn 28, Issue 3, 2016, Pages 78-88

  Litwiniuk, Malgorzata ^a   Krejner, Alicja ^a   Grzela, Tomasz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

extracellular matrix; Hyaluronic acid; inflammation; wound healing

Indexed keywords

ANTIINFLAMMATORY AGENT; HERMES ANTIGEN; HYALURONIC ACID;

DRUG EFFECTS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; METABOLISM; PATHOLOGY; PROCEDURES; REGENERATION; SIGNAL TRANSDUCTION; SOFT TISSUE INJURIES; WOUND HEALING;

ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD44; HUMANS; HYALURONIC ACID; IMMUNOSUPPRESSION; INFLAMMATION; REGENERATION; SIGNAL TRANSDUCTION; SOFT TISSUE INJURIES; WOUND HEALING;

EID: 84961825236     PISSN: 10447946     EISSN: 19432704     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Agren UM, Tammi RH, Tammi MI. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med. 1997;23(7):996-1001.
2. Vigetti D, Karousou E, Viola M, Deleonibus S, De Luca G, Passi A. Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta. 2014;1840(8):2452-2459.
3. Aya KL, Stern R. Hyaluronan in wound healing: rediscovering a major player. Wound Repair Regen. 2014;22(5):579-593.
4. Reed RK, Laurent UB, Fraser JR, Laurent TC. Removal rate of [3H] hyaluronan injected subcutaneously in rabbits. Am J Physiol. 1990;259(2 Pt 2):532-535.
5. Stern R, Jedrzejas M. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818-839.
6. Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR, Stern R. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg. 1991;213(4):292-296.
7. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277(7):4589-4592.
8. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluro-nate. Cell. 1990;61(7):1303-1313.
9. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335.
10. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994; 6(5):726-733.
11. Liang J, Jiang D, Griffith J, et al. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol. 2007;178(4):2469-2475.
12. Svee K, White J, Vaillant P, et al. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest. 1996;98(8):1713-1727.
13. Lesley J, Hascall VC, Tammi M, Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem. 2000;275(35):26967-26975.
14. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11(11):1173-1179.
15. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem. 1997;272(44):27913-27918.
16. Bourguignon LYW, Zhu H, Shao L, Chen YW. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic aciddependent ovarian tumor cell migration. J Biol Chem. 2001;276(10):7327-7336.
17. Vigetti D, Viola M, Karousou E, et al. Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem. 2008;283(7):4448-4458.
18. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P. Hyaluronan-CD44 interaction with leukemiaassociated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 2006;281(20):14026-14040.
19. Hardwick C, Hoare K, Owens R, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol. 1992;117(6):1343-1350
20. Entwistle J, Hall CL, Turley EA. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem. 1996;61(4):569-577.
21. Nikitovic D, Kouvidi K, Karamanos NK, Tzanakakis GN. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. Biomed Res Int. 2013;2013. DOI:10.1155/2013/929531.
22. Kouvidi K, Berdiaki A, Nikitovic D, et al. Role of receptor for hyaluronic acid-mediate motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J Biol Chem. 2011;286(44):38509-38520.
23. Hall CL, Collis LA, Bo AJ, et al. Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion. Matrix Biol. 2001;20(3):183-192.
24. Zaman A, Cui Z, Foley JP, et al. Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Am J Respir Cell Mol Biol. 2005;33(5):447-454.
25. Tolg C, Poon R, Fodde R, Turley EA, Alman BA. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). Oncogene. 2003;22(44):6873-6882.
26. Tolg C, Hamilton SR, Nakrieko KA, et al. Rhamm-/-fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair. J Cell Biol. 2006;175(6):1017-1028.
27. Tolg C, Hamilton SR, Zalinska E, et al. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds. Am J Pathol. 2012;181(4):1250-1270.
28. Hamilton SR, Fard SF, Paiwand FF, et al. The hyaluronan receptors CD44 and RHAMM (CD168) form complexes with ERK 1,2 that sustain high basal motility in breast cancer cells. J Biol Chem. 2007;282(22):16667-16680.
29. Misra S, Hascall V, Markwald R, Ghatak S. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol. 2015;6:201. DOI: 0.3389/fimmu.2015.00201.
30. Scheibner K, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006; 177(2):1272-1281.
31. Harris EN, Kyosseva SV, Weigel JA, Weigel PH. Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). J Biol Chem. 2007;282(5):2785-2797.
32. Zhou B, Weigel JA, Fauss L, Weigel PH. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem. 2000; 275(48):37733-37741.
33. Pandey MS, Baggenstoss BA, Washburn J, Harris EN, Wei-gel PH. The hyaluronan receptor for endocytosis (HARE) activates NF-?B-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans. J Biol Chem. 2013;288(20):14068-14079.
34. Mouta Carreira C, Nasser SM, di Tomaso E, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 2001;61:8079-8084.
35. Wróbel T, Dziegiel P, Mazur G, Zabel M, Kuliczkowski K, Szuba A. LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes. Lymphology. 2005; 38(3):107-110.
36. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem. 2001; 276(22):19420-19430.
37. Nobel PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med. 1996; 183(5):2373-2378.
38. Tremeer C, Benedix F, Sleeman J, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002;195(1):99-111.
39. Termeer CC, Hennies J, Voith U, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol. 2000;165(4):1863-1870.
40. Horton MR, Olman MA, Bao C, et al. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol. 2000;279(4):L707-L715.
41. Horton MR, Shapiro S, Bao C, Lowenstein CJ, Noble PW. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol. 1999;162(7):4171-4176.
42. Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol. 1998;160(6):3023-3030.
43. Hodge-Dufour J, Noble PW, et al. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol. 1997;159(5):2492-2500.
44. McKee CM, Penno MB, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996;98(10):2403-2413.
45. Teder P, Vandivier RW, Jiang D, et al. Resolution of lung inflammation by CD44. Science. 2002; 296(5565):155-158.
46. Litwiniuk M, Grzela T, Samaha R. Chronic inflammation in venous leg ulcer-problems and perspectives. Cent Eur J Immunol. 2009;34(4):247-51.
47. Suga H, Sugaya M, Fujita H, et al. TLR4, rather than TLR2, regulates wound healing through TGF-b and CCL5 expression. J Dermatol Sci. 2014; 73(2):117-124.
48. Iwata Y, Yoshizaki A, Komura K, et al. CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. Am J Pathol. 2009;175(2):649-660.
49. Bourguignon LY, Wong G, Earle CA, Xia W. Interaction of low molecular weight hyaluronan with CD44 and tolllike receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NF?B signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken). 2011;68(12):671-693.
50. Takahashi, R.S. Goomer, F. Harwood, T. Kubo, Y. Hirasawa, D. Amiel. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage. 1999;7(2):182-190.
51. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage. 2006;14(12):1237-1247.
52. Campo GM, Avenoso A, Nastasi G, et al. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta. 2011;1812(9):1170-1181.
53. Pauloin T, Dutot M, Joly F, Warnet JM, Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis. 2009;15:577-583.
54. Pauloin T, Dutot M, Liang H, Chavinier E, Warnet JM, Rat P. Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfateinduced toxic effects. Cornea. 2009;28(9):1032-1041.
55. Pauloin T, Dutot M, Warnet JM, Rat P. In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci. 2008;34(4-5):263-273.
56. Macri A, Scanarotti C, Bassi AM, Giuffrida S, Sangalli G, Traverso CE et al. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2014;253(3):425-430.
57. Ye J, Zhang H, Wu H, et al. Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells. Graefes Arch Clin Exp Ophthalmol. 2012;250(10):1459-1466.
58. Halicka HD, Mitlitski V, Heeter J, Balazs EA, Darzynkiewicz Z. Attenuation of the oxidative burst-induced DNA damage in human leukocytes by hyaluronan. Int J Mol Med. 2009;23(5):695-699.
59. Miki Y, Teramura T, Tomiyama T, et al. Hyaluronan reversed proteoglycan synthesis inhibited by mechanical stress: possible involvement of antioxidant effect. Inflamm Res. 2010;59(6):471-477.
60. Yu CJ, Ko CJ, Hsieh CH, et al. Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acidregulated proteins involved in chondroprotective effect under oxidative stress. J Proteomics. 2014;99:40-53.
61. Ke C, Sun L, Qiao D, Wang D, Zeng X. Antioxidant activity of low molecular weight hyaluronic acid. Food Chem Toxicol. 2011;49(10):2670-2675.
62. Najafi A, Najafi M, Zanganeh Z, Sharafi M, Martinez-Pastor F, Adeldust H. Cryopreservation of ram semen in extenders containing soybean lecithin as cryoprotectant and hyaluronic acid as antioxidant. Reprod Domest Anim. 2014;49(6):934-940.
63. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4(7):528-539.
64. Slevin M, Krupinski J, Gaffney J, et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 2007;26(1):58-68.
65. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem. 2001;276(39):36770-36780.
66. Cao G, Savani RC, Fehrenbach M, et al. Involvement of endothelial CD44 during in vivo angiogenesis. A J Pathol. 2006;169(1):325-336.
67. Hamilton S, Fard S, Paiwand F, et al. The hyaluronan receptors CD44 and RHAMM (CD168) form complexes with ERK 1,2 that sustain high basal motility in breast cancer cells. J Biol Chem. 2007;282(22):16667-16680.
68. Lokeshwar V, Selzer M. Differences in hyaluronic acidmediated functions and signaling in arterial, microvessel and vein-derived human endothelial cells. J Biol Chem. 2000; 275(36):27641-27649.
69. Mo W, Yang C, Liu Y, He Y, Wang Y, Gao F. The influence of hyaluronic acid on vascular endothelial cell proliferation and the relationship with ezrin/merlin expression. Acta Biochim Biphys Sin. 2011;43(12):930-939.
70. Fuchs K, Hippe A, Schmaus A, Homey B, Sleeman JP, Orian-Rousseau V. Opposing effects of high-and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44. Cell Death Dis. 2013;4:e819. DOI: 10.1038/cddis.2013.364.
71. Yang C, Cao M, Liu H, et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem. 2012; 287(51):43094-43107.
72. Neuman MG, Nanau RM, Orunã-Sanchez L, Coto G. Hyaluronic acid and wound healing. J Pharm Pharm Sci. 2015;18(1):53-60.
73. Litwiniuk M, Grzela T. Amniotic membrane: new concepts for an old dressing. Wound Repair Regen. 2014; 22(4):451-456.
74. Litwiniuk M, Bikowska B, Niderla-Bieli?ska J, et al. High molecular weight hyaluronan and stroma-embedded factors of radiation-sterylized amniotic membrane stimulate proliferation of HaCaT cell line in vitro. Cent Eur J Immunol. 2011;36(4):205-211.